
The Rise of iPSCs in Drug Discovery: Regulatory and Legislative Changes Driving the Shift from Animal Models

FDA Modernization Act 2.0: FDA no longer requires all drugs to be tested on animals before human trials

Press release: Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses through their next phase of growth

Press release: Ncardia launches Cellistic, an iPSC cell therapy CDMO

Press release: Ncardia Appoints Andy Holt as Chief Commercial Officer

Press release: Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings